IMAC Holdings (Nasdaq:BACK) - Prezzo delle azioni, notizie e analisi

BACK Panoramica delle azioni

IMAC Holdings, Inc. non ha operazioni significative. Maggiori dettagli

BACK analisi fondamentale
Punteggio fiocco di neve
Valutazione	0/6
Crescita futura	0/6
Prestazioni passate	0/6
Salute finanziaria	3/6
Dividendi	0/6

Analisi del rischio

Non ha una capitalizzazione di mercato significativa ( $2M )

Realizza un fatturato inferiore a 1 milione di dollari ( $0 )

Gli azionisti sono stati sostanzialmente diluiti nell'ultimo anno

Patrimonio netto negativo

+ 2 più rischi

IMAC Holdings, Inc. Concorrenti

SunLink Health Systems

NYSEAM:SSY

US$5.4m

Oncology Institute

NasdaqCM:TOI

US$11.6m

U.S. NeuroSurgical Holdings

OTCPK:USNU

US$20.9m

Inspire Veterinary Partners

NasdaqCM:IVP

US$6.2m

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per IMAC Holdings
Prezzi storici delle azioni
Prezzo attuale dell'azione	US$1.08
Massimo di 52 settimane	US$7.75
Minimo di 52 settimane	US$0.98
Beta	0.26
1Variazione di 1 mese	-14.96%
Variazione a 3 mesi	-37.21%
Variazione di 1 anno	-30.32%
3Variazione a 3 anni	-97.25%
Variazione a 5 anni	-98.17%
Variazione dall'IPO	-99.02%

Notizie e aggiornamenti recenti

Recent updates

IMAC Holdings, Inc.'s (NASDAQ:BACK) Business And Shares Still Trailing The Industry

Apr 18

Is IMAC Holdings (NASDAQ:IMAC) Using Debt In A Risky Way?

Oct 12

IMAC expands Florida presence with Fort Pierce Chiropractic acquisition for undisclosed amount

Jun 14

We Think IMAC Holdings (NASDAQ:IMAC) Has A Fair Chunk Of Debt

Mar 06

Rendimenti per gli azionisti

	BACK	US Healthcare	US Mercato
7D	5.9%	1.6%	2.2%
1Y	-30.3%	2.1%	31.6%

Ritorno vs Industria: BACK ha avuto una performance inferiore rispetto al US Healthcare che ha registrato un rendimento 2.1 % nell'ultimo anno.

Rendimento vs Mercato: BACK ha avuto una performance inferiore al mercato US che ha registrato un rendimento 31.6 % nell'ultimo anno.

Volatilità dei prezzi

Is BACK's price volatile compared to industry and market?
BACK volatility
BACK Average Weekly Movement	11.6%
Healthcare Industry Average Movement	6.8%
Market Average Movement	6.3%
10% most volatile stocks in US Market	15.7%
10% least volatile stocks in US Market	3.1%

Prezzo delle azioni stabile: Il prezzo delle azioni di BACK è stato volatile negli ultimi 3 mesi.

Volatilità nel tempo: La volatilità settimanale di BACK è diminuita da 24% a 12% nell'ultimo anno, ma è comunque superiore al 75% delle azioni US.

Informazioni sull'azienda

Fondato	I dipendenti	AMMINISTRATORE DELEGATO	Sito web
2000	3	Faith Zaslavsky	www.imacholdings.com

IMAC Holdings, Inc. non ha operazioni significative. In precedenza, possedeva e gestiva centri di rigenerazione di cure mediche innovative e cliniche backspace. La società è stata fondata nel 2000 e ha sede a Brentwood, nel Tennessee.

IMAC Holdings, Inc. Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di IMAC Holdings con la sua capitalizzazione di mercato?
BACK statistiche fondamentali
Capitalizzazione di mercato	US$1.86m
Guadagni(TTM)	-US$5.63m
Ricavi(TTM)	n/a

0.0x

Rapporto P/S

-0.3x

Rapporto P/E

BACK è sopravvalutato?

Vedi Fair Value e analisi di valutazione

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
BACK Conto economico (TTM)
Ricavi	US$0
Costo del fatturato	US$860.77k
Profitto lordo	-US$860.77k
Altre spese	US$4.77m
Guadagni	-US$5.63m

Ultimi guadagni dichiarati

Mar 31, 2024

Prossima data di guadagno

n/a

Utile per azione (EPS)	-3.27
Margine lordo	0.00%
Margine di profitto netto	0.00%
Rapporto debito/patrimonio netto	0%

Come si è comportato BACK nel lungo periodo?

Vedi performance storica e confronto

BACK Panoramica delle azioni

Analisi del rischio

IMAC Holdings, Inc. Concorrenti

NYSEAM:SSY

US$5.4m

NasdaqCM:TOI

US$11.6m

OTCPK:USNU

US$20.9m

NasdaqCM:IVP

US$6.2m

Storia dei prezzi e prestazioni

Notizie e aggiornamenti recenti

IMAC Holdings Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10 Q

IMAC Holdings, Inc. announced delayed 10-Q filing

IMAC Holdings, Inc. announced that it expects to receive $3.74 million in funding from a group of investors

Imac Holdings Inc. Announces the Launch of an Entirely New Precision Oncology Assay for Breast Cancer Treatment Decision Making Utilizing the Reverse Phase Protein Array (Rppa) Technology Through Its Newly Established Subsidiary, Ignite Proteomics Llc

IMAC Holdings, Inc. Announces Resignation of Cary Sucoff as Director

IMAC Holdings, Inc. announced delayed 10-Q filing

Recent updates

IMAC Holdings Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10 Q

IMAC Holdings, Inc. announced delayed 10-Q filing

IMAC Holdings, Inc. announced that it expects to receive $3.74 million in funding from a group of investors

Imac Holdings Inc. Announces the Launch of an Entirely New Precision Oncology Assay for Breast Cancer Treatment Decision Making Utilizing the Reverse Phase Protein Array (Rppa) Technology Through Its Newly Established Subsidiary, Ignite Proteomics Llc

IMAC Holdings, Inc. Announces Resignation of Cary Sucoff as Director

IMAC Holdings, Inc. announced delayed 10-Q filing

IMAC Holdings, Inc. announced that it has received $1 million in funding

IMAC Holdings, Inc. has filed a Follow-on Equity Offering in the amount of $10 million.

IMAC Holdings, Inc. Announces Chief Executive Officer Changes

IMAC Holdings, Inc. Announces Board Resignations

Theralink Technologies, Inc. (OTCPK:THER) cancelled the acquisition of IMAC Holdings, Inc. (NasdaqCM:BACK) in a reverse merger transaction.

IMAC Holdings, Inc. announced delayed annual 10-K filing

Insufficient new directors

IMAC Holdings, Inc. Announces Executive Changes

IMAC Holdings Receives Letter from Nasdaq Regarding Non-Compliance with the Minimum Stockholders’ Equity Requirement of $2.5 Million for Continued Listing on the Nasdaq Capital Market Under Listing Rule 5550(b)(1)

IMAC Holdings, Inc. announced delayed 10-Q filing

Insufficient new directors

IMAC Holdings, Inc. Regains Compliance with Nasdaq Listing Requirements

IMAC Holdings, Inc. Receive Non-Compliance Letter from Nasdaq

IMAC Holdings, Inc. Announces 1-for-30 Reverse Stock Split to Regain Compliance

Price target decreased by 17% to US$1.25

IMAC Holdings Provides Nasdaq Compliance Update Regarding Minimum Stockholders' Equity Requirement and Minimum Bid Price Requirement

IMAC Holdings, Inc. announced that it has received $4.3 million in funding from Theralink Technologies, Inc. and other investors

IMAC Holdings, Inc., Annual General Meeting, Jul 05, 2023

IMAC Holdings Receives A Non-Compliance Letter from the Listing Qualifications Department of the Nasdaq Stock Market

Theralink Technologies, Inc. (OTCPK:THER) entered into a definitive agreement and plan of merger to acquire IMAC Holdings, Inc. (NasdaqCM:BACK) in a reverse merger transaction.

IMAC Holdings, Inc. announced delayed 10-Q filing

IMAC Holdings, Inc.'s (NASDAQ:BACK) Business And Shares Still Trailing The Industry

Consensus forecasts updated

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Price target decreased to US$5.00

IMAC Holdings, Inc. Launches E-Commerce Website for Vitamin and Supplement Line

IMAC Holdings Receives Notice from The Nasdaq Stock Market Regarding Minimum Bid Price Requirement

IMAC Holdings, Inc. Announces Completion of Third Cohort of Its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson's Disease

Consensus estimates of losses per share improve by 10%

IMAC Holdings, Inc. Announces Addition of Medical Weight Loss Services to IMAC Regeneration Centers

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

IMAC Holdings, Inc. has completed a Follow-on Equity Offering in the amount of $3.925 million.

IMAC Holdings, Inc. Adds Stretch Services At the Backspace

Price target decreased to US$5.50

IMAC Holdings, Inc. Announces the Launch of Spinal Health and Wellness Products and Supplements

IMAC Holdings, Inc., Annual General Meeting, Jul 06, 2022

IMAC Holdings, Inc. announced delayed annual 10-K filing

IMAC Holdings, Inc. Announces Completion of Second Cohort of Its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson’S Disease

IMAC Holdings, Inc. Announces Executive Changes

Imac Holdings, Inc. Announces Relocates of Growing Clinic in St. Louis Area

Third quarter 2021 earnings released: US$0.068 loss per share (vs US$0.12 loss in 3Q 2020)

Is IMAC Holdings (NASDAQ:IMAC) Using Debt In A Risky Way?

Consensus EPS estimates fall to -US$0.38

Price target decreased to US$3.50

Second quarter 2021 earnings released: US$0.15 loss per share (vs US$0.20 loss in 2Q 2020)

IMAC Holdings, Inc. Announces Initiation of Second Cohort of Its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson’s Disease

IMAC Holdings Launches Acute Care Services for Musculoskeletal Injuries

IMAC Holdings, Inc. (NasdaqCM:IMAC) agreed to acquire Active Medical Center Ltd.

IMAC Holdings, Inc. (NasdaqCM:IMAC) acquired Fort Pierce Chiropractic.

IMAC expands Florida presence with Fort Pierce Chiropractic acquisition for undisclosed amount

Imac Holdings, Inc. Introduces the Back Space - First In-Store Chiropractic and Spinal Care Location Within Walmart

Consensus EPS estimates increase to -US$0.34

Consensus revenue estimates fall to US$14.3m

First quarter 2021 earnings released: US$0.15 loss per share (vs US$0.18 loss in 1Q 2020)